申请人:Bayer Aktiengesellschaft
公开号:US04048171A1
公开(公告)日:1977-09-13
1,4-Dihydropyridines of the formula: ##STR1## wherein R is hydrogen, straight, branched or cyclic lower alkyl, lower alkenyl, or lower alkinyl, unsubstituted or substituted; or benzyl, or phenethyl, unsubstituted or substituted in the aryl portion; R' is alkyl of 1 to 4 carbon atoms; R" is alkenyl of 2 to 6 carbon atoms, alkinyl of 2 to 6 carbon atoms, cyclic alkenyl of 3 to 6 carbon atoms interrupted by oxygen, alkenyl of 2 to 6 carbon atoms or alkinyl of 2 to 6 carbon atoms interrupted by 1 or 2 oxygen atoms, or alkenyl of 2 to 6 carbon atoms or alkinyl of 2 to 6 carbon atoms substituted by hydroxyl; and R'"is unsubstituted or substituted aryl; cyclohexyl; benzyl; styryl; pyridyl; pyrimidyl; furyl; thienyl; pyrrolyl; pyridyl, pyrrolyl, thienyl or furyl substituted by alkyl of 1 or 2 carbon atoms; or substituted pyrimidyl: ##STR2## are useful for their coronary dilating effect, their nitrite-like effect on the heart, their anti-fibrillation effect, their vascular-spasmolytic effect and muscular-spasmolytic effect, and as anti-hypertensives.
公式为:##STR1##
其中,R为氢,直链,支链或环状低碳基,低碳烯基或低碳炔基,未取代或取代;或苄基,或苯乙基,未取代或取代芳基部分;R'为1至4个碳原子的烷基;R"为2至6个碳原子的烯基,2至6个碳原子的炔基,被氧断裂的3至6个碳原子的环状烯基,2至6个碳原子的烯基或2至6个碳原子的炔基,被1或2个氧原子打断的,或2至6个碳原子的烯基或2至6个碳原子的炔基,被羟基取代;R'"为未取代或取代的芳基;环己基;苄基;苯乙烯基;吡啶基;嘧啶基;呋喃基;噻吩基;吡咯基;被1或2个碳原子取代的吡啶基,吡咯基,噻吩基或呋喃基;或取代的嘧啶基:##STR2##
它们对于其冠状动脉扩张作用,其类硝酸盐对心脏的作用,其抗心房颤动作用,其血管痉挛作用和肌肉痉挛作用以及作为降压药物而有用。